Showing 785 articles by Liz Highleyman

Filters Author: Liz Highleyman

Liz is a medical writer and editor with interests in HIV, hepatitis and cancer. She has contributed conference news reporting for NAM since 2004. Twitter: @LizHighleyman

Hepatitis C symptoms & diagnosis

Hepatitis C and HIV

About HIV
December 2017
Hepatitis B

Hepatitis B treatment for people with HIV

About HIV
December 2017
Hepatitis B

Hepatitis B and HIV

About HIV
December 2017
Liver disease

Fatty liver disease and HIV

About HIV
December 2017
HIV testing programmes & uptake

Many Americans still get their HIV diagnosis years after infection

News
30 November 2017
Hepatitis C treatment

More work and lower drug prices are needed to eliminate hepatitis C worldwide

News
29 November 2017
Hepatitis C treatment

Sofosbuvir/ledipasvir for 8 weeks cures acute HCV in people with HIV

News
28 November 2017
Cancer

Nivolumab improves outcomes in liver cancer study

News
14 November 2017
Hepatitis C treatment

Curing hepatitis C with DAAs linked to 71% reduction in liver cancer

News
30 October 2017
Hepatitis B

Daily aspirin therapy linked to lower liver cancer risk

News
26 October 2017
People who inject drugs

Hepatitis C testing linked to reduced opioid use among people who inject drugs

News
25 October 2017
Hepatitis C treatment

Maviret cures most people with HCV genotype 3 and those with cirrhosis

News
24 October 2017
Hepatitis C transmission & prevention

HCV infection is rising among HIV-positive gay men in San Diego

News
24 October 2017
Hepatitis C treatment

Hepatitis C cure leads to improved quality of life

News
23 October 2017
HIV treatment

Symtuza protease inhibitor regimen maintains viral suppression for a year

News
13 October 2017
Antibody-based treatment

Long-acting monoclonal antibody effective against multidrug-resistant HIV

News
12 October 2017
Cancer

US FDA approves nivolumab immunotherapy for liver cancer

News
28 September 2017
Hepatitis C transmission & prevention

Does drug injection equipment other than syringes transmit hepatitis C?

News
20 September 2017
HIV prevention policy

San Francisco annual report shows continued drop in new HIV infections

News
18 September 2017
PrEP programmes & uptake

No new HIV infections among Kaiser PrEP users, but data shows missed opportunities

News
7 September 2017
Drug interactions & pharmacokinetics

Trans women wary of antiretroviral drug and hormone interactions

News
23 August 2017
Health problems & ageing

People with HIV are at risk for liver fibrosis and steatosis

News
21 August 2017
PrEP programmes & uptake

PrEP use in US exceeds 100,000 in Gilead pharmacy survey

News
14 August 2017
New & experimental hepatitis C treatment

European and US regulators approve AbbVie's new combo for all hepatitis C genotypes

News
7 August 2017